Educational objectives
- Drive the importance of the need to reach higher treatment targets in patients with immune-mediated inflammatory diseases of the skin and joints to improve patient satisfaction and health-related quality of life
- Recognise the need for a “correct” diagnosis in patients with suspected axial spondyloarthritis for optimised management and outcomes
- Be aware of the revised International Psoriasis Council categorisation of psoriasis
- Understand how digital approaches may facilitate early diagnosis of psoriasis, and more targeted and streamlined access to rheumatological care for spondyloarthritis
Meet the faculty
Prof Robert
Landewé
(The Netherlands)
Prof José-Manuel
Carrascosa
(Spain)
Educational objectives
- Explore inflammatory pathways in immune-mediated inflammatory disease, including the role of interleukin (IL)-17 vs. IL-23 cytokines, and Janus kinase inhibitors
- Discuss evolving treatment considerations in spondyloarthritis and the molecular differences for patients who are bionaive and those who have had an inadequate response to anti-tumour necrosis factor (TNF-IR) treatment
- Recognise the advances in targeted immune-based therapies for psoriasis
- Revisit perspectives on psoriasis disease severity and the importance of aligning with specific patient needs and preferences
- Delve into the updated guidelines for more proactive treatment to meet higher treatment goals
Meet the faculty
Prof Brian
Kirby
(Ireland)
Prof Lars Erik
Kristensen
(Denmark)
Educational objectives
- Define the pathobiological relationship between psoriasis and psoriatic arthritis
- Identify the risk factors and early indicators of psoriatic arthritis, and appreciate the importance of prompt referral and timely intervention
- Discuss how evidence is helping shape best-practice management approaches
- Explore initiatives and potential biomarkers advancing the diagnosis and treatment of psoriatic arthritis
Meet the faculty
Prof Frank
Behrens
(Germany)
Prof Diamant
Thaçi
(Germany)
How can we help?
If you need help, please contact your local UCB representative or email at info@immunologysummitucb.com
Report an adverse event
This website is neither intended nor designed to record or report adverse events. If you have adverse events to report for a UCB product, please follow the current regulatory procedure in force in your country or go to this link:
Report an adverse event